pindolol has been researched along with Infant, Premature, Diseases in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thies, WR | 1 |
| Reinhardt, D | 1 |
| Rutschke, A | 1 |
| Kusenbach, G | 1 |
| Ludwig, J | 1 |
1 other study available for pindolol and Infant, Premature, Diseases
| Article | Year |
|---|---|
[Postnatal development of the sympathoadrenergic system in premature and newborn infants].
Topics: Adult; Blood Platelets; Cyclic AMP; Epinephrine; Gestational Age; Humans; Infant, Newborn; Infant, P | 1986 |